The effect of aprotinin on outcome after coronary-artery bypass grafting. Shaw AD, Stafford-Smith M, White WD, Phillips-Bute B, Swaminathan M, Milano C, Welsby IJ, Aronson S, Mathew JP, Peterson ED, Newman MF (2008) N Engl J Med 358: 784-93 The evolution of medical and surgical therapy for coronary artery disease. A 15-year perspective. Califf RM, Harrell FE, Lee KL, Rankin JS, Hlatky MA, Mark DB, Jones RH, Muhlbaier LH, Oldham HN, Pryor DB (1989) JAMA 261: 2077-86 Problems and advantages of an observational data base approach to evaluating the effect of therapy on outcome. Rosati RA, Lee KL, Califf RM, Pryor DB, Harrell FE (1982) Circulation 65: 27-32 Current prognosis of ischemic mitral regurgitation. Implications for future management. Hickey MS, Smith LR, Muhlbaier LH, Harrell FE, Reves JG, Hinohara T, Califf RM, Pryor DB, Rankin JS (1988) Circulation 78: I51-9 Survival of coronary artery disease patients with stable pain and normal left ventricular function treated medically or surgically at Duke University. Whalen RE, Harrell FE, Lee KL, Rosati RA (1982) Circulation 65: 49-52 Determinants of early versus late cardiac death in patients undergoing coronary artery bypass graft surgery. Smith LR, Harrell FE, Rankin JS, Califf RM, Pryor DB, Muhlbaier LH, Lee KL, Mark DB, Jones RH, Oldham HN (1991) Circulation 84: III245-53 Changing efficacy of coronary revascularization. Implications for patient selection. Califf RM, Harrell FE, Lee KL, Rankin JS, Mark DB, Hlatky MA, Muhlbaier LH, Wechsler AS, Jones RH, Oldham HN (1988) Circulation 78: I185-91 Surgical survival benefits for coronary disease patients with left ventricular dysfunction. Bounous EP, Mark DB, Pollock BG, Hlatky MA, Harrell FE, Lee KL, Rankin JS, Wechsler AS, Pryor DB, Califf RM (1988) Circulation 78: I151-7 Randomized trials of coronary artery bypass surgery: impact on clinical practice at Duke University Medical Center. Califf RM, Hlatky MA, Mark DB, Lee KL, Harrell FE, Rosati RA, Pryor DB (1985) Circulation 72: V136-44 Continuing evolution of therapy for coronary artery disease. Initial results from the era of coronary angioplasty. Mark DB, Nelson CL, Califf RM, Harrell FE, Lee KL, Jones RH, Fortin DF, Stack RS, Glower DD, Smith LR (1994) Circulation 89: 2015-25 The changing survival benefits of coronary revascularization over time. Pryor DB, Harrell FE, Rankin JS, Lee KL, Muhlbaier LH, Oldham HN, Hlatky MA, Mark DB, Reves JG, Califf RM (1987) Circulation 76: V13-21 Angiotensin-converting enzyme inhibition alters the fibrinolytic response to cardiopulmonary bypass. Pretorius M, Murphey LJ, McFarlane JA, Vaughan DE, Brown NJ (2003) Circulation 108: 3079-83 Observational comparison of event-free survival with medical and surgical therapy in patients with coronary artery disease. 20 years of follow-up. Muhlbaier LH, Pryor DB, Rankin JS, Smith LR, Mark DB, Jones RH, Glower DD, Harrell FE, Lee KL, Califf RM (1992) Circulation 86: II198-204 Comparison of predictions based on observational data with the results of randomized controlled clinical trials of coronary artery bypass surgery. Hlatky MA, Califf RM, Harrell FE, Lee KL, Mark DB, Pryor DB (1988) J Am Coll Cardiol 11: 237-45 Emergency coronary artery bypass surgery for percutaneous coronary interventions: changes in the incidence, clinical characteristics, and indications from 1979 to 2003. Yang EH, Gumina RJ, Lennon RJ, Holmes DR, Rihal CS, Singh M (2005) J Am Coll Cardiol 46: 2004-9 Prevalence and clinical course of pleural effusions at 30 days after coronary artery and cardiac surgery. Light RW, Rogers JT, Moyers JP, Lee YC, Rodriguez RM, Alford WC, Ball SK, Burrus GR, Coltharp WH, Glassford DM, Hoff SJ, Lea JW, Nesbitt JC, Petracek MR, Starkey TD, Stoney WS, Tedder M (2002) Am J Respir Crit Care Med 166: 1567-71 Angiotensin-converting enzyme inhibition and smoking potentiate the kinin response to cardiopulmonary bypass. Pretorius M, McFarlane JA, Vaughan DE, Brown NJ, Murphey LJ (2004) Clin Pharmacol Ther 76: 379-87 Percutaneous intervention versus coronary artery bypass graft surgery in left main coronary artery stenosis: a systematic review and meta-analysis. Zhang XL, Zhu QQ, Yang JJ, Chen YH, Li Y, Zhu SH, Xie J, Wang L, Kang LN, Xu B (2017) BMC Med 15: 84 P-selectin 1087G/A polymorphism is associated with neuropsychological test performance in older adults with cardiovascular disease. Gunstad J, Benitez A, Hoth KF, Spitznagel MB, McCaffery J, McGeary J, Kakos LS, Poppas A, Paul RH, Jefferson AL, Sweet LH, Cohen RA (2009) Stroke 40: 2969-72 Trends in acute renal failure associated with coronary artery bypass graft surgery in the United States. Swaminathan M, Shaw AD, Phillips-Bute BG, McGugan-Clark PL, Archer LE, Talbert S, Milano CA, Patel UD, Stafford-Smith M (2007) Crit Care Med 35: 2286-91 Eotaxin-3 and interleukin-5 pleural fluid levels are associated with pleural fluid eosinophilia in post-coronary artery bypass grafting pleural effusions. Kalomenidis I, Stathopoulos GT, Barnette R, Guo Y, Peebles RS, Blackwell TS, Light RW (2005) Chest 127: 2094-100 Symptomatic persistent post-coronary artery bypass graft pleural effusions requiring operative treatment : clinical and histologic features. Lee YC, Vaz MA, Ely KA, McDonald EC, Thompson PJ, Nesbitt JC, Light RW (2001) Chest 119: 795-800 Agreement of self-reported comorbid conditions with medical and physician reports varied by disease among end-stage renal disease patients. Merkin SS, Cavanaugh K, Longenecker JC, Fink NE, Levey AS, Powe NR (2007) J Clin Epidemiol 60: 634-42 Comparison of analytic models for estimating the effect of clinical factors on the cost of coronary artery bypass graft surgery. Dudley RA, Harrell FE, Smith LR, Mark DB, Califf RM, Pryor DB, Glower D, Lipscomb J, Hlatky M (1993) J Clin Epidemiol 46: 261-71 Intraoperative systolic blood pressure variability predicts 30-day mortality in aortocoronary bypass surgery patients. Aronson S, Stafford-Smith M, Phillips-Bute B, Shaw A, Gaca J, Newman M, Cardiothoracic Anesthesiology Research Endeavors (2010) Anesthesiology 113: 305-12 Tissue factor and platelet glycoprotein Ib-alpha alleles are associated with age at first coronary bypass operation. Donahue BS, Byrne DW, Gailani D, George AL (2003) Anesthesiology 99: 1287-94 Nephrology quiz and questionnaire: renal replacement therapy. Golper TA, Discussant, Glassock RJ, Bleyer AJ (2012) Clin J Am Soc Nephrol 7: 1347-52 Mycotic pseudoaneurysm of an aortic bypass graft and contiguous vertebral osteomyelitis due to Aspergillus fumigatus. Brandt SJ, Thompson RL, Wenzel RP (1985) Am J Med 79: 259-62 Hospital outcomes in major teaching, minor teaching, and nonteaching hospitals in New York state. Polanczyk CA, Lane A, Coburn M, Philbin EF, Dec GW, DiSalvo TG (2002) Am J Med 112: 255-61 Relationship of genetic variability and depressive symptoms to adverse events after coronary artery bypass graft surgery. Phillips-Bute B, Mathew JP, Blumenthal JA, Morris RW, Podgoreanu MV, Smith M, Stafford-Smith M, Grocott HP, Schwinn DA, Newman MF, Perioperative Genetics and Safety Outcomes Investigative Team (2008) Psychosom Med 70: 953-9 Underuse of invasive procedures among Medicaid patients with acute myocardial infarction. Philbin EF, McCullough PA, DiSalvo TG, Dec GW, Jenkins PL, Weaver WD (2001) Am J Public Health 91: 1082-8 Perioperative intravenous acetaminophen attenuates lipid peroxidation in adults undergoing cardiopulmonary bypass: a randomized clinical trial. Billings FT, Petracek MR, Roberts LJ, Pretorius M (2015) PLoS One 10: e0117625 Genome-wide assessment for genetic variants associated with ventricular dysfunction after primary coronary artery bypass graft surgery. Fox AA, Pretorius M, Liu KY, Collard CD, Perry TE, Shernan SK, De Jager PL, Hafler DA, Herman DS, DePalma SR, Roden DM, Muehlschlegel JD, Donahue BS, Darbar D, Seidman JG, Body SC, Seidman CE (2011) PLoS One 6: e24593 Association of gain-of-function EPHX2 polymorphism Lys55Arg with acute kidney injury following cardiac surgery. Shuey MM, Billings FT, Wei S, Milne GL, Nian H, Yu C, Brown NJ (2017) PLoS One 12: e0175292 Measuring the therapeutic efficacy of coronary revascularization: Implications for future management. Rankin JS, Harrell FE (2006) J Thorac Cardiovasc Surg 131: 944-8 Combination of two urinary biomarkers predicts acute kidney injury after adult cardiac surgery. Katagiri D, Doi K, Honda K, Negishi K, Fujita T, Hisagi M, Ono M, Matsubara T, Yahagi N, Iwagami M, Ohtake T, Kobayashi S, Sugaya T, Noiri E (2012) Ann Thorac Surg 93: 577-83 Impact of early renal recovery on survival after cardiac surgery-associated acute kidney injury. Swaminathan M, Hudson CC, Phillips-Bute BG, Patel UD, Mathew JP, Newman MF, Milano CA, Shaw AD, Stafford-Smith M (2010) Ann Thorac Surg 89: 1098-104 Exposure to topical bovine thrombin during surgery elicits a response against the xenogeneic carbohydrate galactose alpha1-3galactose. Schoenecker JG, Hauck RK, Mercer MC, Parker W, Lawson JH (2000) J Clin Immunol 20: 434-44 Perioperative outcomes among patients with end-stage renal disease following coronary artery bypass surgery in the USA. Parikh DS, Swaminathan M, Archer LE, Inrig JK, Szczech LA, Shaw AD, Patel UD (2010) Nephrol Dial Transplant 25: 2275-83 Thoracic epidural anesthesia & analgesia in patients undergoing coronary artery bypass surgery. Riedel BJ, Shaw AD (2002) Anesth Analg 94: 1365; author reply 1366
Hints: (1) double-click or double-tap to navigate to a node. (2) Grab a node and move it to arrange the graph.